Christian Cortis - 20 Jun 2024 Form 4 Insider Report for Tectonic Therapeutic, Inc. (TECX)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
24 Jun 2024, 16:16:36 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Lochner, Attorney-in-Fact

Key filing fact

Christian Cortis filed Form 4 for Tectonic Therapeutic, Inc. (TECX) on 24 Jun 2024.

Key facts

  • This page summarizes Christian Cortis's Form 4 filing for Tectonic Therapeutic, Inc. (TECX).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 24 Jun 2024, 16:16.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECX transaction

Common Stock

Award

Transaction value
Shares
+126,368
Change %
Price
Shares after
126,368
Date
20 Jun 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECX transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares
+56,061
Change %
Price
Shares after
56,061
Date
20 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
56,061
Exercise price
$2.38
Footnotes
F2, F3, F4
TECX transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares
+18,704
Change %
Price
Shares after
18,704
Date
20 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
18,704
Exercise price
$5.38
Footnotes
F2, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Received in exchange for 236,458 shares of common stock of Tectonic Therapeutic, Inc., a Delaware corporation ("Tectonic"), pursuant to an Agreement and Plan of Merger dated as of January 30, 2024 (the "Merger Agreement") by and among AVROBIO, Inc., a Delaware corporation ("AVROBIO"), Tectonic and Alpine Merger Subsidiary, Inc., a direct, wholly owned subsidiary of AVROBIO (the "Merger Sub"). Under the terms of the Merger Agreement, on June 20, 2024, Merger Sub merged with and into Tectonic (the "Merger"), with Tectonic surviving the Merger as a wholly owned subsidiary of AVROBIO. Upon the closing of the Merger, each share of Tectonic common stock was converted into the right to receive 0.534419990 shares of the Issuer's common stock, after giving effect to a reverse stock split of the Issuer's common stock of 1-for-12. Subsequent to the Merger, the name of the Issuer was changed from AVROBIO, Inc. to Tectonic Therapeutic, Inc.

Footnote F2

Upon the closing of the Merger, each outstanding option to purchase shares of Tectonic common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock, on the same terms and conditions as were applicable to such Tectonic stock option prior to the Merger, as adjusted for the exchange ratio and the reverse stock split.

Footnote F3

22,508 shares subject to the option are fully vested. The remaining shares subject to the option vest in 10 equal monthly installments beginning on June 30, 2024, such that the option will be fully vested on March 31, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Footnote F4

Received in exchange for a stock option to acquire 104,901 shares of Tectonic common stock pursuant to the Merger Agreement.

Footnote F5

The shares subject to the option vest in 48 equal monthly installments beginning on December 1, 2023, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Footnote F6

Received in exchange for a stock option to acquire 35,000 shares of Tectonic common stock pursuant to the Merger Agreement.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .